| abstract |
The present invention includes one or more pharmaceutically acceptable excipients and an active pharmaceutical ingredient ("API") that is a compound of Formula A1 or A2 or a pharmacologically acceptable salt, solvate or hydrate thereof, wherein the API is exposed to a basic compound. It relates to a solid phase pharmaceutical composition that does not. |